SGLT2 Inhibitors: Drug Safety Communication - Labels to Include Warnings About Too Much Acid in the Blood and Serious Urinary Tract Infections
Labeling changes describe risks of ketoacidosis, urosepsis and pyelonephritis.
Source: FDA MedWatch - Category: American Health Source Type: news
More News: American Health | Pyelonephritis | SGLT2 Inhibitors | Urinary Tract Infections | Warnings